Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

2.825 +0.405 (+16.74%)

Streaming Delayed Price Updated: 3:00 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Volume	6,087,520
Open	2.410
Bid (Size)	2.820 (800)
Ask (Size)	2.830 (300)
Prev. Close	2.420
Today's Range	2.373 - 3.060
52wk Range	1.010 - 3.190
Shares Outstanding	45,052,904
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Reports Q3 2025 Earnings Beat Amidst Stock Decline ↗

November 10, 2025

Zentalis (ZNTL) beat Q3 2025 earnings estimates. The biotech firm has no revenue but a strong cash position, with key data for its lead drug, azenosertib, expected in late 2026.

Via Chartmill

Performance

YTD	+106.2%	+106.2%
1 Month	+100.4%	+100.4%
3 Month	+72.3%	+72.3%
6 Month	+115.6%	+115.6%
1 Year	-5.5%	-5.5%

More News

Zentalis (ZNTL) Q2 Loss Narrows 70% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 26, 2025

Via Benzinga

(ZNTL) - Analyzing Zentalis Pharma's Short Interest ↗

June 21, 2024

Via Benzinga

Here are the top movers in Wednesday's session. ↗

February 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

January 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers ↗

September 16, 2024

Via Benzinga

Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL

August 19, 2024

From Newman Ferrara LLP

Via Business Wire

Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 13, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024 ↗

August 09, 2024

Via InvestorPlace

ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

August 01, 2024

From The Schall Law Firm

Via Business Wire

Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 ↗

June 22, 2024

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 19, 2024

Via Benzinga

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 18, 2024

Via Benzinga

Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 18, 2024

Via Benzinga

ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

Via Talk Markets

Frequently Asked Questions

Is Zentalis Pharmaceuticals, Inc. - common stock publicly traded?

Yes, Zentalis Pharmaceuticals, Inc. - common stock is publicly traded.

What exchange does Zentalis Pharmaceuticals, Inc. - common stock trade on?

Zentalis Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock?

The ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock is ZNTL on the Nasdaq Stock Market

What is the current price of Zentalis Pharmaceuticals, Inc. - common stock?

The current price of Zentalis Pharmaceuticals, Inc. - common stock is 2.825

When was Zentalis Pharmaceuticals, Inc. - common stock last traded?

The last trade of Zentalis Pharmaceuticals, Inc. - common stock was at 01/08/26 03:00 PM ET

What is the market capitalization of Zentalis Pharmaceuticals, Inc. - common stock?

The market capitalization of Zentalis Pharmaceuticals, Inc. - common stock is 127.27M

How many shares of Zentalis Pharmaceuticals, Inc. - common stock are outstanding?

Zentalis Pharmaceuticals, Inc. - common stock has 127M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.